BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26140865)

  • 1. Effects of intrauterine growth restriction on sleep and the cardiovascular system: The use of melatonin as a potential therapy?
    Yiallourou SR; Wallace EM; Miller SL; Horne RS
    Sleep Med Rev; 2016 Apr; 26():64-73. PubMed ID: 26140865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction.
    Miller SL; Yawno T; Alers NO; Castillo-Melendez M; Supramaniam VG; VanZyl N; Sabaretnam T; Loose JM; Drummond GR; Walker DW; Jenkin G; Wallace EM
    J Pineal Res; 2014 Apr; 56(3):283-94. PubMed ID: 24456220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of preterm infants with intrauterine growth restriction.
    Fang S
    Early Hum Dev; 2005 Nov; 81(11):889-900. PubMed ID: 16266791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the development of melatonin rhythmicity in humans.
    Kennaway DJ; Goble FC; Stamp GE
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1525-32. PubMed ID: 8636362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses?
    Morrison JL; Botting KJ; Soo PS; McGillick EV; Hiscock J; Zhang S; McMillen IC; Orgeig S
    J Pregnancy; 2012; 2012():839656. PubMed ID: 23227338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal melatonin administration mitigates coronary stiffness and endothelial dysfunction, and improves heart resilience to insult in growth restricted lambs.
    Tare M; Parkington HC; Wallace EM; Sutherland AE; Lim R; Yawno T; Coleman HA; Jenkin G; Miller SL
    J Physiol; 2014 Jun; 592(12):2695-709. PubMed ID: 24710061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal growth restriction is worse than extreme prematurity for the developing lung.
    Soudée S; Vuillemin L; Alberti C; Mohamed D; Becquet O; Farnoux C; Biran V; Baud O
    Neonatology; 2014; 106(4):304-10. PubMed ID: 25170598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopment in children with intrauterine growth restriction: adverse effects and interventions.
    Wang Y; Fu W; Liu J
    J Matern Fetal Neonatal Med; 2016; 29(4):660-8. PubMed ID: 25758617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular function in children born very preterm after intrauterine growth restriction with severely abnormal umbilical artery blood flow.
    Morsing E; Liuba P; Fellman V; Maršál K; Brodszki J
    Eur J Prev Cardiol; 2014 Oct; 21(10):1257-66. PubMed ID: 23613223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fetal cardiovascular score to predict infant hypertension and arterial remodeling in intrauterine growth restriction.
    Cruz-Lemini M; Crispi F; Valenzuela-Alcaraz B; Figueras F; Gómez O; Sitges M; Bijnens B; Gratacós E
    Am J Obstet Gynecol; 2014 Jun; 210(6):552.e1-552.e22. PubMed ID: 24368136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feeding preterm infants today for later metabolic and cardiovascular outcomes.
    Lapillonne A; Griffin IJ
    J Pediatr; 2013 Mar; 162(3 Suppl):S7-16. PubMed ID: 23445851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early hemodynamic consequences of patent ductus arteriosus in preterm infants with intrauterine growth restriction.
    Rakza T; Magnenant E; Klosowski S; Tourneux P; Bachiri A; Storme L
    J Pediatr; 2007 Dec; 151(6):624-8. PubMed ID: 18035142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early alteration of structural and functional brain development in premature infants born with intrauterine growth restriction.
    Tolsa CB; Zimine S; Warfield SK; Freschi M; Sancho Rossignol A; Lazeyras F; Hanquinet S; Pfizenmaier M; Huppi PS
    Pediatr Res; 2004 Jul; 56(1):132-8. PubMed ID: 15128927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications due to malnutrition and intrauterine growth restriction in preterm newborns].
    Arteaga-Mancera MP; Rendón-Macías ME; Iglesias-Leboreiro J; Bernárdez-Zapata I; Ortiz-Maldonado F
    Rev Med Inst Mex Seguro Soc; 2014; 52(2):204-11. PubMed ID: 24758861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term and long-term sequelae in intrauterine growth retardation (IUGR).
    Longo S; Bollani L; Decembrino L; Di Comite A; Angelini M; Stronati M
    J Matern Fetal Neonatal Med; 2013 Feb; 26(3):222-5. PubMed ID: 23030765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DOHaD: long-term impact of perinatal diseases (IUGR and prematurity)].
    Storme L; Luton D; Abdennebi-Najar L; Le Huërou-Luron I
    Med Sci (Paris); 2016 Jan; 32(1):74-80. PubMed ID: 26850610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intrauterine growth restriction on long-term health.
    Salam RA; Das JK; Bhutta ZA
    Curr Opin Clin Nutr Metab Care; 2014 May; 17(3):249-54. PubMed ID: 24613859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peculiarity of cyclic sleep organization and production of melatonin in intrauterine growth retardation's newborns].
    Evsiukova II; Koval'chuk-Kovalevskaia OV; Maslianiuk NA; Dodkhoev DS
    Fiziol Cheloveka; 2013; 39(6):63-71. PubMed ID: 25509173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of intrauterine growth restriction: cardiovascular disorders.
    Demicheva E; Crispi F
    Fetal Diagn Ther; 2014; 36(2):143-53. PubMed ID: 23948759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroencephalographic characteristics in preterm infants born with intrauterine growth restriction.
    Yerushalmy-Feler A; Marom R; Peylan T; Korn A; Haham A; Mandel D; Yarkoni I; Bassan H
    J Pediatr; 2014 Apr; 164(4):756-761.e1. PubMed ID: 24485822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.